News

Extensive and timely coverage of the institutional industry.

Consultant/OCIO/Discretionary
Midwest Plan Retains Consultant; Concludes Opportunistic Credit Mgr. Search

The plan retained its general investment consultant and hired two opportunistic credit managers at a special investment board meeting last week.

08.09.21
Multi-Asset/Investment Advisor
Southwest County Seeking Investment Advisor

The selected firm will manage the county operational portfolio and bond proceeds.

08.09.21
Fixed-Income
West Coast Plan Nears Core Bond Search Conclusion

The plan will hear detailed information on three core fixed-income finalists this week.

08.09.21
International / Global / Emerging Markets
Mid-Atlantic Deferred Comp Plan To Review Int’l Fund Alternatives

The plan will review alternatives to its incumbent international large-cap equity fund, which was placed on watch in May.

08.09.21
Administrator/Record Keeper
Midwest 457 Plan Wraps Up Investment, Record Keeping Search

The plan rehired its incumbent provider this summer following an RFP issued in the first quarter.

08.09.21
Consultant/OCIO/Discretionary
Midwest Plan Begins Consultant Search

The plan has issued its general investment consultant RFP due to its incumbent’s contract expiration.

08.09.21
People Moves
Paradice Names N. American Distribution Head

He will lead all aspects of sales, consultant relations, client service and marketing.

08.09.21
In The News
DB Funding Levels Remain Stable Following Initial Covid Recovery

UK defined benefit (DB) pension scheme funding levels failed to improve for the time since the onset of the pandemic over the past quarter.

08.09.21
In The News
Distressed Debt Fund SVP Bets Europe Will Have Long ‘Hangover’ From Covid

Region likely to throw up opportunities for funds focusing on shaky corporate debt, says founder.

08.09.21
In The News
Third-Largest U.S. Pension Scooped Up EV Stocks, Covid-Vaccine Makers

The New York State Common Retirement Fund bought EV stocks including Nikola, Lordstown, and NIO, and vaccine makers BioNTech, Moderna, and Novavax in the second quarter.

08.09.21